Contribute to science and discover new insights

Join our Harvard study

Contribute to science and discover new insights

Join our Harvard study

Contribute to science and discover new insights

Join our Harvard study

Contribute to science and discover new insights

Join our Harvard study

Press Releases & News

illumicell AI Wins 2nd Prize in Google Cloud Competition at HumanX, Las Vegas

2025 March
Illumicell AI achieved a significant milestone by securing second place in the Google Cloud Startup Competition at the inaugural HumanX 2025 conference in Las Vegas.
Read More

Pulse 2.0 interview with Jeyla

May 2025
In a recent interview with Pulse 2.0, illumicell AI co-founder and CSO Jeyla Sadikova shared insights into the company's mission to revolutionize male fertility diagnostics through real-time, AI-powered cellular imaging.
Read More

illumicell AI Secures $2M to Deliver Lab-Grade Fluid Diagnostics in Minutes at the Point-of-Care

May 2025
Illumicell AI, a Swiss-American techmed startup, has secured $2 million in pre-seed funding to advance its portable “lab scanner” and real-time AI platform for fluid-based diagnostics, initially focusing on male fertility.
Read More

illumicell AI Installs the first US system at Harvard Pagliuca Life Lab

May 2025
llumicell AI has installed its first U.S.-based LuceDx system at Harvard's Pagliuca Life Lab, marking a significant milestone in the company's expansion.
Read More

Harvard Tokyo Center for Technology & Entrepreneuship

May 2025
Join us for an energizing panel discussion exploring how Swiss/US-based illumicell AI is working with Japanese investors and advisors to redefine the future of diagnostics.
Read More

illumicell AI LSI Asia panel announcement

May 2025
Illummicell participated as speakers at LSI Asia ‘25 in Singapore, joining two key panel discussions on the future of maternal and fetal health and the evolving role of clinicians as investors in medtech innovation.
Read More

illumicell AI Raised $2M in Pre-Seed

May 2025
Illumicell AI has successfully raised $2 million in a pre-seed funding round, underscoring strong investor confidence in their mission to transform maternal and fetal health diagnostics.
Read More

Join Our Mission

Thank you for reaching out!

We’ve received your inquiry and will get back to you within 3 business days.
Oops! Something went wrong while submitting the form.